355
Views
9
CrossRef citations to date
0
Altmetric
In Vitro and Animal Studies

Effect of urolithins on oxidative stress of colorectal adenocarcinomacells-Caco-2

, , , , & ORCID Icon
Pages 952-959 | Received 28 Feb 2017, Accepted 05 May 2017, Published online: 23 May 2017

References

  • Aqil F, Gupta A, Munagala R, Jeyabalan J, Kausar H, Sharma RJ, Singh IP, Gupta RC. 2012. Antioxidant and antiproliferative activities of anthocyanin/ellagitannin-enriched extracts from Syzygium cumini L. (Jamun, the Indian Blackberry). Nutr Cancer. 64:428–438.
  • Arapitsas P. 2012. Hydrolyzable tannin analysis in food. Food Chem. 135:1708–1717.
  • Bakkalbasi E, Mentes O, Artik N. 2009. Food ellagitannins-occurrence, effects of processing and storage. Crit Rev Food Sci Nutr. 49:283–298.
  • Benetou V, Orfanos P, Lagiou P, Trichopoulos D, Boffetta P, Trichopoulou A. 2008. Vegetables and fruits in relation to cancer risk: evidence from the Greek EPIC cohort study. Cancer Epidemiol Biomarkers Prev. 17:387–392.
  • Boffetta P, Couto E, Wichmann J, Ferrari P, Trichopoulos D, Bueno-de-Mesquita HB, van Duijnhoven FJ, et al. 2010. Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer I. 102:529–537.
  • Cathcart R, Schwiers E, Ames BN. 1983. Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay. Anal Biochem. 134:111–116.
  • Cerdá B, Llorach R, Cerón JJ, Espín CJ, Tomás-Barberán AF. 2003. Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice. Eur J Nutr. 42:18–28.
  • Cerdá B, Tomás-Barberán FA, Espín JC. 2005. Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: identification of biomarkers and individual variability. J Agric Food Chem. 53:227–235.
  • Chan FK-M, Moriwaki K, De Rosa MJ. 2013. Detection of necrosis by release of lactate dehydrogenase (LDH) activity. In: Methods in molecular biology. Clifton: New Jersey; p. 65–70.
  • Eberhardt MV, Jeffery EH. 2006. When dietary antioxidants perturb the thiol redox. J Sci Food Agric. 86:1996–1998.
  • Espin JC, Larrosa M, Garcia-Conesa M, Tomas-Barberan F. 2013. Biological significance of urolithins, the gut microbial ellagic acid-derived metabolites: the evidence so far. Evid Based Complement Alternat Med. 2013:15.
  • Garcia-Villalba R, Espin JC, Tomas-Barberan FA. 2016. Chromatographic and spectroscopic characterization of urolithins for their determination in biological samples after the intake of foods containing ellagitannins and ellagic acid. J Chromatog A. 1428:162–175.
  • Gerhauser C, Klimo K, Heiss E, Neumann I, Gamal-Eldeen A, Knauft J, Liu GY, et al. 2003. Mechanism-based in vitro screening of potential cancer chemopreventive agents. Mutat-Res. 523–524:163–172.
  • Giménez-Bastida JA, González-Sarrías A, Larrosa M, Tomás-Barberán F, Espín JC, García-Conesa M-T. 2012. Ellagitannin metabolites, urolithin A glucuronide and its aglycone urolithin A, ameliorate TNF-α-induced inflammation and associated molecular markers in human aortic endothelial cells. Mol Nutr Food Res. 56:784–796.
  • Glade MJ. 1999. Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition. 15:523–526.
  • Gonzalez-Sarrias A, Espin JC, Tomas-Barberan FA, Garcia-Conesa MT. 2009. Gene expression, cell cycle arrest and MAPK signalling regulation in Caco-2 cells exposed to ellagic acid and its metabolites, urolithins. Mol Nutr Food Res. 53:686–698.
  • González-Sarrías A, García-Villalba R, Núñez-Sánchez MÁ, Tomé-Carneiro J, Zafrilla P, Mulero J, Tomás-Barberán FA, Espín JC. 2015. Identifying the limits for ellagic acid bioavailability: a crossover pharmacokinetic study in healthy volunteers after consumption of pomegranate extracts. J Funct Foods. 19:225–235.
  • Gonzalez-Sarrias A, Miguel V, Merino G, Lucas R, Morales JC, Tomas-Barberan F, Alvarez AI, Espin JC. 2013. The gut microbiota ellagic acid-derived metabolite urolithin A and its sulfate conjugate are substrates for the drug efflux transporter breast cancer resistance protein (ABCG2/BCRP). J Agric Food Chem. 61:4352–4359.
  • Gonzalez-Sarrias A, Nunez-Sanchez MA, Garcia-Villalba R, Tomas-Barberan FA, Espin JC. 2015. Antiproliferative activity of the ellagic acid-derived gut microbiota isourolithin A and comparison with its urolithin A isomer: the role of cell metabolism. Eur J Nutr. 56:831–841.
  • Gonzalez-Sarrias A, Nunez-Sanchez MA, Tome-Carneiro J, Tomas-Barberan FA, Garcia-Conesa MT, Espin JC. 2016. Comprehensive characterization of the effects of ellagic acid and urolithins on colorectal cancer and key-associated molecular hallmarks: MicroRNA cell specific induction of CDKN1A (p21) as a common mechanism involved. Mol Nutr Food Res. 60:701–716.
  • Ishimoto H, Tai A, Yoshimura M, Amakura Y, Yoshida T, Hatano T, Ito H. 2012. Antioxidative properties of functional polyphenols and their metabolites assessed by an ORAC assay. Biosci Biotec Biochem. 76:395–399.
  • Jafari S, Saeidnia S, Abdollahi M. 2014. Role of natural phenolic compounds in cancer chemoprevention via regulation of the cell cycle. Curr Pharm Biotechnol. 15:409–421.
  • Key TJ. 2011. Fruit and vegetables and cancer risk. Br J Cancer. 104:6–11.
  • Khansari N, Shakiba Y, Mahmoudi M. 2009. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat Inflamm Allergy Drug Discov. 3:73–80.
  • Legrand C, Bour JM, Jacob C, Capiaumont J, Martial A, Marc A, Wudtke M, et al. 1992. Lactate dehydrogenase (LDH) activity of the cultured eukaryotic cells as marker of the number of dead cells in the medium [corrected]. J Biotechnol. 25:231–243.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem. 193:265–275.
  • Mele L, Mena P, Piemontese A, Marino V, Lopez-Gutierrez N, Bernini F, Brighenti F, et al. 2016. Antiatherogenic effects of ellagic acid and urolithins in vitro. Arch Biochem Biophys. 599:42–50.
  • Nunez-Sanchez MA, Karmokar A, Gonzalez-Sarrias A, Garcia-Villalba R, Tomas-Barberan FA, Garcia-Conesa MT, Brown K, Espin JC. 2016. In vivo relevant mixed urolithins and ellagic acid inhibit phenotypic and molecular colon cancer stem cell features: a new potentiality for ellagitannin metabolites against cancer. Food Chem Tox. 92:8–16.
  • Perše M. 2013. Oxidative stress in the pathogenesis of colorectal cancer: cause or consequence? BioMed Res Inter. 2013:9.
  • Pfundstein B, Haubner R, Wurtele G, Gehres N, Ulrich CM, Owen RW. 2014. Pilot walnut intervention study of urolithin bioavailability in human volunteers. J Agric Food Chem. 62:10264–10273.
  • Porter WL. 1980. Recent trends in food applications of antioxidants. In: Autoxidation in food and biological systems. Boston, MA: Springer US; p. 295–365.
  • Priyadarsini KI, Khopde SM, Kumar SS, Mohan H. 2002. Free radical studies of ellagic acid, a natural phenolic antioxidant. J Agric Food Chem. 50:2200–2206.
  • Saha P, Yeoh BS, Singh R, Chandrasekar B, Vemula PK, Haribabu B, Vijay-Kumar M, Jala VR. 2016. Gut microbiota conversion of dietary ellagic acid into bioactive phytoceutical urolithin A inhibits heme peroxidases. PLoS One. 11:e0156811
  • Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, Nair MG, Heber D. 2005. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem. 16:360–367.
  • Seeram NP, Aronson WJ, Zhang Y, Henning SM, Moro A, Lee RP, Sartippour M, et al. 2007. Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. J Agric Food Chem. 55:7732–7737.
  • Soobrattee MA, Bahorun T, Aruoma OI. 2006. Chemopreventive actions of polyphenolic compounds in cancer. BioFactors. 27:19–35.
  • Strober W. 2001. Trypan blue exclusion test of cell viability. Curr Protoc Immunol. 100:157–163.
  • Surh Y-J. 1999. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutat Res. 428:305–327.
  • Tomas-Barberan FA, Garcia-Villalba R, Gonzalez-Sarrias A, Selma MV, Espin JC. 2014. Ellagic acid metabolism by human gut microbiota: consistent observation of three urolithin phenotypes in intervention trials, independent of food source, age, and health status. J Agric Food Chem. 62:6535–6538.
  • Wang X, Ouyang Y, Liu J, Zhu M, Zhao G, Bao W, Hu FB. 2014. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ. 349:g4490
  • Whitley AC, Sweet DH, Walle T. 2006. Site-specific accumulation of the cancer preventive dietary polyphenol ellagic acid in epithelial cells of the aerodigestive tract. J Pharm Pharmacol. 58:1201–1209.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.